SARS CoV 2 News and Research

RSS

Universal Coronavirus vaccine could save billions in U.S., new study suggests

The epidemiologic, clinical, and economic value of a universal coronavirus disease 2019 (COVID-19) vaccine.

15 Jan 2024

mRNA COVID-19 vaccines highly effective in preventing hospitalizations among adolescents in Nordic study

Study evaluated the effectiveness of mRNA COVID-19 vaccines (BNT162b2, mRNA-1273, and heterologous schedules) in preventing hospitalization among adolescents in Nordic countries, finding high protection rates of 73% to 86% at six months.

14 Jan 2024

Paxlovid treatment in 20% of COVID-19 patients could avert 850,000 hospitalizations, save up to $170 billion

A study in the Emerging Infectious Diseases journal shows treating 20% of COVID-19 patients with Paxlovid could save up to 0.85 million lives and reduce the economic burden by US $170.17 billion in the US.

14 Jan 2024

Immune dysregulation in long COVID patients uncovered in new study

Sstudy reveals significant immune changes in long COVID patients, including altered T cell responses and systemic inflammation, using advanced 'omics' and serological assays.

14 Jan 2024

Bivalent COVID-19 vaccines show higher effectiveness against thromboembolic events

Study finds bivalent mRNA COVID-19 vaccines are more effective than monovalent vaccines in preventing thromboembolic events in older adults and those with end-stage renal disease.

14 Jan 2024

JN.1 variant's spread not due to enhanced immune escape, study suggests

Study finds the JN.1 variant of SARS-CoV-2 may not have increased immune escape ability compared to its predecessor BA.2.86, suggesting other factors for its rapid spread.

14 Jan 2024

New study reveals higher mortality risk in COVID-19 patients with newly-diagnosed atrial fibrillation

The incidence and prognosis of newly diagnosed AF in patients hospitalized due to SARS-CoV-2.

12 Jan 2024

Going green reduces COVID risk: Plant-based diets slash risk by up to 41%

Study finds plant-based diets reduce COVID-19 risk by 39-41% compared to meat-based diets, also associated with healthier BMI and lower obesity rates.

11 Jan 2024

Study shows lasting T-cell immunity in healthcare workers against SARS-CoV-2 variants

Study reveals robust memory T-cell responses to SARS-CoV-2 in healthcare workers over 1.5 years post-Omicron, suggesting durable immunity against highly mutated variants.

11 Jan 2024

Duration of virus exposure plays a major role in COVID-19 transmission, study finds

A study published today in Nature shows that the NHS COVID-19 contact tracing app successfully predicted people's risk of catching the virus following exposure to an infected person.

11 Jan 2024

A universal coronavirus vaccine could provide substantial health and economic benefits

What if scientists had developed a universal coronavirus vaccine in the years prior to 2020 so that it was available at the start of the COVID-19 pandemic?

11 Jan 2024

BNT162b2 vaccine effectiveness in preventing SARS-CoV-2 infection and severe disease

The BNT162b2 vaccine’s effectiveness in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

11 Jan 2024

Phylogenomic analysis to generate early warning signs for COVID-19 waves

The Transmission Fitness Polymorphism (TFP) scanner analysis pipeline to detect severe acute respiratory syndrome coronavirus 2.

11 Jan 2024

Research reveals COVID-19's lasting impact on brain function and structure

Study investigates post-COVID-19 cognitive defects, finding that SARS-CoV-2 infections are linked to brain injury markers and reduced cingulate cortex volume, with corticosteroids offering some cognitive protection.

10 Jan 2024

Study shows engineered antibodies significantly boost Omicron neutralization

Researchers engineered IgA antibodies from IgG monoclonals, enhancing neutralization against Omicron by up to 75-fold and offering protection in mice models.

10 Jan 2024

Pangolins' genetic makeup linked to increased coronavirus susceptibility

Research reveals pangolins' vulnerability to coronavirus due to innate immune gene pseudogenization, impacting their antiviral response.

10 Jan 2024

Understanding unique characteristics of SARS-Cov-2 JN.1 variant and adapting public health strategies

Announcing a new article publication for Zoonoses journal. The relentless evolution of SARS-CoV-2 variants remains a formidable challenge to global public health, thus prompting significant concern among health authorities due to emergent strains.

10 Jan 2024

Research reveals how light can help destroy infectious coronavirus particles

New research has revealed how light can be used to destroy infectious coronavirus particles that contaminate surfaces.

10 Jan 2024

New intranasal vaccine candidate triggers powerful mucosal defense against SARS-CoV-2

A team of scientists, led by Duke-NUS Medical School, has discovered a potential intranasal vaccine candidate that provides improved, longer-lasting immunity against SARS-CoV-2 viruses compared to when given as an injection.

10 Jan 2024

Nasal drops with IgA antibodies may protect against COVID-19 and future variants

Researchers at Karolinska Institutet in Sweden have shown that nasal drops with IgA antibodies can protect mice from SARS-CoV-2 infection.

10 Jan 2024

SARS CoV 2 News and Research

Universal Coronavirus vaccine could save billions in U.S., new study suggests

mRNA COVID-19 vaccines highly effective in preventing hospitalizations among adolescents in Nordic study

Paxlovid treatment in 20% of COVID-19 patients could avert 850,000 hospitalizations, save up to $170 billion

Immune dysregulation in long COVID patients uncovered in new study

Bivalent COVID-19 vaccines show higher effectiveness against thromboembolic events

JN.1 variant's spread not due to enhanced immune escape, study suggests

New study reveals higher mortality risk in COVID-19 patients with newly-diagnosed atrial fibrillation

Going green reduces COVID risk: Plant-based diets slash risk by up to 41%

Study shows lasting T-cell immunity in healthcare workers against SARS-CoV-2 variants

Duration of virus exposure plays a major role in COVID-19 transmission, study finds

A universal coronavirus vaccine could provide substantial health and economic benefits

BNT162b2 vaccine effectiveness in preventing SARS-CoV-2 infection and severe disease

Phylogenomic analysis to generate early warning signs for COVID-19 waves

Research reveals COVID-19's lasting impact on brain function and structure

Study shows engineered antibodies significantly boost Omicron neutralization

Pangolins' genetic makeup linked to increased coronavirus susceptibility

Understanding unique characteristics of SARS-Cov-2 JN.1 variant and adapting public health strategies

Research reveals how light can help destroy infectious coronavirus particles

New intranasal vaccine candidate triggers powerful mucosal defense against SARS-CoV-2

Nasal drops with IgA antibodies may protect against COVID-19 and future variants

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News